Numis Securities Ltd downgraded shares of Abcam Plc (LON:ABC) to an add rating in a research report report published on Monday, Market Beat Ratings reports. The brokerage currently has GBX 700 ($9.97) price objective on the stock.

A number of other brokerages have also recently issued reports on ABC. Stifel Nicolaus reissued a hold rating on shares of Abcam Plc in a report on Wednesday, November 11th. JPMorgan Chase & Co. reissued a neutral rating and issued a GBX 506 ($7.21) target price on shares of Abcam Plc in a report on Thursday, October 22nd. Canaccord Genuity raised Abcam Plc to a hold rating and set a GBX 432 ($6.15) target price for the company in a report on Monday, November 2nd. Finally, Peel Hunt reissued a buy rating and issued a GBX 660 ($9.40) target price on shares of Abcam Plc in a report on Monday. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and two have issued a buy rating to the company. The company has an average rating of Hold and a consensus target price of GBX 534.86 ($7.62).

Shares of Abcam Plc (LON:ABC) opened at 642.0000 on Monday. Abcam Plc has a one year low of GBX 260.50 and a one year high of GBX 674.00. The stock’s 50 day moving average price is GBX 622.12 and its 200 day moving average price is GBX 590.15. The stock’s market capitalization is GBX 1.29 billion.

In other Abcam Plc news, insider Hirzel,Alan Thomas purchased 3,335 shares of the company’s stock in a transaction that occurred on Wednesday, November 11th. The stock was purchased at an average cost of GBX 580 ($8.26) per share, with a total value of £19,343 ($27,558.06).

Abcam plc is a producer and distributor of antibodies and associated protein research products. The Company develops and manufactures its own products, as well as externally sourcing products. The Company’s product includes Primary antibodies, including RabMAbs (LON:ABC), Secondary antibodies, Functional assays, ELISA and other kits, Biochemicals, Isotype controls, Flow cytometry multi-color selector, Kits, Loading controls, Lysates, Peptides, Proteins, Slides, Tags and cell markers and Tools and Reagents. The Company’s subsidiaries include Abcam Inc, Abcam KK, Abcam (Hong Kong) Limited, Ascent Scientific Limited, Epitomics Inc, Epitomics (Hangzhou) Biotechnology Co. Limited and MitoSciences Inc

Receive News & Ratings for Abcam Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abcam Plc and related companies with MarketBeat.com's FREE daily email newsletter.